Sema4 launched high-capacity COVID-19 testing to address critical need across Connecticut and New York
On Apr. 6, 2020, new COVID-19 estimated find that, among European nations, the peak daily death rate from…
AIM ImmunoTech announced NCI award of $14.54 million to study Ampligen as part of five Roswell Park-led chemokine modulation clinical trials in melanoma, colorectal and ovarian cancers
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
AIM ImmunoTech and Shenzhen Smoore Technology announced research agreement to develop, easy-to-use treatment approach for the SARS-CoV-2 Pandemic
On Apr. 6, 2020, AIM ImmunoTech announced a Material Transfer and Research Agreement (MTA) with Shenzhen Smoore Technology…
New antiviral drug from Emory University heading into clinical trials for COVID-19 treatment
On Apr. 6, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced its participation in a clinical trial…
Innovation Pharma in discussions to advance Brilacidin into human trials against COVID-19
On Apr. 6, 2020, Innovation Pharma announced that it is engaged in discussions with health care provider networks…
3M and White House announced plan to import 166.5 million additional respirators into the U.S. over the next three months
On Apr. 6, 2020, 3M and the White House announced a plan to import 166.5 million respirators over…
University of Minnesota Twin Cities designed respirator mask prototypes from filter technology
On Apr. 6, 2020, to address the need for N95 masks, an interdisciplinary research team at the University…
3M partnered with Cummins to increase production of filters for powered air purifying respirators
On Apr. 6, 2020, 3M announced a partnership with Cummins to increase the production of high efficiency particulate…
Partners with hospitals nationwide to provide prioritized testing to inpatients with suspected COVID-19
On Apr. 6, 2020, BioReference Laboratories, an OPKO Health company, announced that it will continue to prioritize COVID-19…
CSL Group collaborated with global plasma leaders to accelerate development of COVID-19 hyperimmune therapy
On Apr. 6, 2020, Biotest, BPL Group, LFB, and Octapharma joined an alliance formed by CSL Behring and…
INOVIO initiated phase 1 clinical trial of its COVID-19 vaccine
On Apr. 6, 2020, Inovio Pharma announced the U.S. Food and Drug Administration (FDA) had accepted the company’s…
OraSure Technologies received BARDA contract for Rapid Oral Fluid Pan-SARS-Coronavirus in-home self-test
On Apr. 6, 2020, OraSure Technologies announced it had been awarded a $710,310 contract from the Biomedical Advanced…
USDA confirmed COVID-19 in a tiger in New York Zoo
On Apr. 6, 2020, the USDA confirmed SARS-CoV-2 (the virus that causes COVID-19 in humans) in one tiger…
Luminex received FDA Emergency Use Authorization for ARIES SARS-CoV-2 assay to detect virus responsible for COVID-19 disease
On Apr. 6, 2020, Luminex announced announced that the FDA has issued an Emergency Use Authorization for its…
VGXI supported rapid timeline to clinical testing for Coronavirus vaccine
On Apr. 6, 2020, VGXI, announced it had completed manufacturing and release of a DNA vaccine to combat…
VGXI established pilot mRNA manufacturing capabilities
On Apr. 6, 2020, VGX announced successful implementation of new RNA production services through completion of all Phase…
Rice University established COVID-19 research fund
On Apr. 6, 2020, Rice University announced it had established a research accelerator fund to support projects –…
New IHME COVID-19 forecasts find lower hospital bed need, epidemics starting to peak confirms social distancing works
On Apr. 5, 2020, updated COVID-19 estimates from the Institute for Health Metrics and Evaluation (IHME) found that…
Minneapolis Heart Institute Foundation engaged in COVID-19 STEMI research study
On Apr. 6, 2020, the Minneapolis Heart Institute Foundation (MHIF) announced it was serving as the international coordinating…
Biotechnology | COVID-19 | Diagnostics | Influenza | Life Science News | Non-Profit Research | Therapeutics
Mesa Biotech to develop molecular point-of-care diagnostic test for novel Coronavirus (COVID-19)
On Apr. 4, 2020, Mesa Biotech announced the addition of the novel coronavirus (SARS-CoV-2) to its active influenza…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Neurology | NIH | Therapeutics
Single mutation leads to big effects in autism-related gene
On Apr. 3, 2020, a new study in Neuron offers clues to why autism spectrum disorder (ASD) is…
3M response to Defense Production Act Order
On Apr. 3, 2020, 3M announced that the Administration formally invoked the Defense Production Act to require 3M…
Mayo Clinic named national site for Convalescent Plasma Expanded Access Program
On Apr. 3, 2020, the FDA announced that the Mayo Clinic Mayo Clinic will be the lead institution…
University of Minnesota created on-site testing facility for COVID-19
On Apr. 3, 2020, the University of Minnesota announced it had created the stateï¾’s fourth on-site testing facility…
University of Nebraska developed a COVID-19 screening mobile app
On Apr. 3, 2020, UNMC aunched a groundbreaking mobile app for Apple Iphone to screen large groups of…
BD, BioGX announced FDA Emergency Use Authorization for new COVID-19 diagnostic for use in U.S.
On Apr. 3, 2020, BD (Becton, Dickinson) and BioGX announced that the U.S. Food and Drug Administration (FDA)…
Clinical trial for severely ill COVID-19 patients begun at Montefiore-Einstein
On Apr. 3, 2020, Montefiore Health System and Albert Einstein College of Medicine started treating very sick COVID-19…
OHSU launched in-house COVID-19 testing lab
On Apr. 3, 2020, Oregon Health & Science University (OHSU) announced that it had established an in-house COVID-19…
Mary and Ryan Finley donated $3 million to Legacy Health, OHSU to combat COVID-19
On Apr. 3, 2020, Oregon Health & Science University (OHSU) announced that Mary and Ryan Finley, moved by…
Penn Medicine launched trial to evaluate hydroxychloroquine to treat, prevent COVID-19
On Apr. 3, 2020, a trial led by the Perelman School of Medicine at the University of Pennsylvania…